In addition to tacrolimus, dimethyl fumarate and secukinumab (an anti‐IL17A antibody) were also found to be protective in psoriasis by compromising IL‐17‐mediated induction of IκBζ.46, 77. This evidence concerns the gene NFKBIZ and psoriasis.